Real-world survival of relapsed compared to de-novo stage IV diagnosis of advanced non-small cell lung cancer Published September 2019 Citation Kerrigan, KC, Halland, B, Adamson, BJS, Patel, SB, Akerley, WL. . World Conference on Lung Cancer. . https://wclc2019.iaslc.org/wp-content/uploads/2019/08/WCLC2019-Abstract-Book_web-friendly.pdf#page=328 Authors:Kerrigan, KC, Halland, B, Adamson, BJS, Patel, SB, Akerley, WL Sources:World Conference on Lung Cancer Share Posted inPublicationsUnmet needNon-small cell lung cancer More publicationsASCO Annual MeetingMay 2026Drivers of organotropism and patterns of metastatic progression in metastatic non-small cell lung cancerPublication summaryPublicationsNon-small cell lung cancerASCO Annual MeetingMay 2026Digital twin models for counterfactual prediction in NSCLC: a validation study using clinical trial dataCohen AB, Giffith S, Estevez M, et al.Publication summaryPublicationsNon-small cell lung cancerArtificial intelligenceASCO Annual MeetingMay 2026Machine learning risk stratification in a US-based database to identify subgroups of patients with PD-L1-high NSCLC who benefit from adding chemotherapy to pembrolizumabOrcutt X, Nimgaonkar V, Sun L, et al.Publication summaryPublicationsMachine learningComparative effectivenessNon-small cell lung cancerArtificial intelligence